EMD-25663
SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map
EMD-25663
Single-particle3.0 Å
Deposition: 08/12/2021Map released: 24/08/2022
Last modified: 19/06/2024
Sample Organism:
Severe acute respiratory syndrome coronavirus 2,
Escherichia coli
Sample: Complex of SARS CoV-2 S, Spike Glycoprotein, variant D614G with Antibody 2-7 scFv
Fitted models: 7t3m
Deposition Authors: Byrne PO
,
McLellan JS
Sample: Complex of SARS CoV-2 S, Spike Glycoprotein, variant D614G with Antibody 2-7 scFv
Fitted models: 7t3m
Deposition Authors: Byrne PO
,
McLellan JS
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern.
Chang MR ,
Tomasovic L ,
Kuzmina NA ,
Ronk AJ ,
Byrne PO ,
Johnson R ,
Storm N ,
Olmedillas E,
Hou YJ ,
Schafer A ,
Leist SR,
Tse LV ,
Ke H ,
Coherd C ,
Nguyen K,
Kamkaew M ,
Honko A ,
Zhu Q,
Alter G ,
Saphire EO ,
McLellan JS ,
Griffiths A ,
Baric RS ,
Bukreyev A ,
Marasco WA
(2022) Nat Commun , 13 , 5814 - 5814
,
Tomasovic L ,
Kuzmina NA ,
Ronk AJ ,
Byrne PO ,
Johnson R ,
Storm N ,
Olmedillas E,
Hou YJ ,
Schafer A ,
Leist SR,
Tse LV ,
Ke H ,
Coherd C ,
Nguyen K,
Kamkaew M ,
Honko A ,
Zhu Q,
Alter G ,
Saphire EO ,
McLellan JS ,
Griffiths A ,
Baric RS ,
Bukreyev A ,
Marasco WA
(2022) Nat Commun , 13 , 5814 - 5814